Início
Mercados
Gráficos e ideias
Algo
Notícias
Store
Corretoras
Baixar
Calendário econômico
Sinais de Negociação
Terminal web
Pressione
/
para pesquisar: @user, $symbol, ...
Pesquisar
Login
Criar uma conta
Deutsch
English
Русский
中文
Español
Português
日本語
한국어
Français
Italiano
Türkçe
IBRX
#815
ImmunityBio, Inc. Common Stock
9.7
8
+3.93%
Setor:
Base:
Moeda do lucro:
Faixa diária
Faixa anual
Mudança diária
+3.93%
Mudança mensal
+63.00%
Mudança em 6 meses
+312.66%
Mudança anual
+213.46%
Fechamento anterior
9.4
1
Open
9.7
8
Bid
Ask
Low
9.7
8
High
9.7
8
Volume
189
Mercados
Ações
Cuidados de saúde
IBRX
Open full chart
Financials
Overview
Relatórios
Statistics
Dividends
Quarterly
Annual
Value
Q3, 24
Q4, 24
Q1, 25
Q2, 25
Q3, 25
Q4, 25
TTM
Dividends per share
—
—
—
—
—
—
—
Dividend yield %
—
—
—
—
—
—
—
Payout ratio %
—
—
—
—
—
—
—
Notícias
ImmunityBio: Direktor verkauft Aktien im Wert von 900.000 US-Dollar
Simon, director, sells ImmunityBio (IBRX) shares worth $900k
ImmunityBio: Positive Studiendaten zu Blasenkrebs – Rekrutierung vorzeitig abgeschlossen
ImmunityBio completes enrollment in bladder cancer trial
ImmunityBio Investors Rally Behind Cancer Trial Milestone - ImmunityBio (NASDAQ:IBRX)
Netflix and Palantir among market cap stock movers on Wednesday
ImmunityBio Supersedes Expectations With Fivefold Revenue Increase - ImmunityBio (NASDAQ:IBRX)
AMD and Keysight Technologies among market cap stock movers on Tuesday
Tesla, Oracle among market cap stock movers on Monday
H.C. Wainwright hebt Kursziel für Immunitybio-Aktie auf 15 $ an
H.C. Wainwright raises Immunitybio stock price target to $15
ImmunityBio (IBRX) Reports Q4 Loss, Beats Revenue Estimates